Los antileucotrienos en el tratamiento del asma

Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report. Update on Selected Topics 2002. National Heart, Lung and Blood Institute. Disponible en http://www.nhlbi.nih.gov/guidelines/asthma/index.htm Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. 2002. Disponible en http://www.ginasthma.com 1997 Adkins, 1998, Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma, Drugs, 55, 121, 10.2165/00003495-199855010-00008 Schoors, 1995, Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers, Br J Clin Pharmacol, 40, 277, 10.1111/j.1365-2125.1995.tb05785.x Zhao, 1997, Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers, Biopharm Drug Dispos, 18, 769, 10.1002/(SICI)1099-081X(199712)18:9<769::AID-BDD60>3.0.CO;2-K Cheng, 1996, Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females, Pharm Res, 13, 445, 10.1023/A:1016056912698 Hui, 1991, Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist, Lancet, 337, 1062, 10.1016/0140-6736(91)91709-4 Kemp, 1999, Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma, J Fam Pract, 48, 425 García-Marcos, 2001, Antileukotrienes in asthma: present situation, Expert Opin Pharmacother, 2, 441, 10.1517/14656566.2.3.441 Edelman, 2000, Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group, Ann Intern Med, 132, 97, 10.7326/0003-4819-132-2-200001180-00002 Bisgaard, 2000, Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children, Am J Respir Crit Care Med, 162, 187, 10.1164/ajrccm.162.1.9910039 Henderson WR, 2002, A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model, Am J Respir Crit Care Med, 165, 108, 10.1164/ajrccm.165.1.2105051 Knorr, 2001, Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years, Pediatrics, 108, E48, 10.1542/peds.108.3.e48 Bisgaard, 1999, NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast, Am J Respir Crit Care Med, 160, 1227, 10.1164/ajrccm.160.4.9903004 Pearlman, 2000, Effectiveness and tolerability of zafirlukast for the treatment of asthma in children, Clin Ther, 22, 732, 10.1016/S0149-2918(00)90007-9 Knorr, 1998, Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group, Jama, 279, 1181, 10.1001/jama.279.15.1181 Ducharme, 2002, Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children, Cochrane Database Syst Rev, cD002314 Simons, 2001, Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study, J Pediatr, 138, 694, 10.1067/mpd.2001.112899 Ducharme, 2001, Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma, Cochrane Database Syst Rev, cD003133 Nelson, 2000, Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast, J Allergy Clin Immunol, 106, 1088, 10.1067/mai.2000.110920 Fish, 2001, Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy, Chest, 120, 423, 10.1378/chest.120.2.423 Stempel, 2002, Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs, J Allergy Clin Immunol, 109, 433, 10.1067/mai.2002.121953 O'Sullivan, 2003, Effect of the Addition of Montelukast to inhaled Fluticasone Propionate on airway inflammation, Am J Respir Crit Care Med, 167, 745, 10.1164/rccm.200208-783OC Churg, 1951, Allergy granulomatosis, allergic angiitis and polyarteritis nodosa, Am J Pathol, 27, 277 Bisgaard, 2003, A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis, Am J Respir Crit Care Med, 167, 379, 10.1164/rccm.200207-747OC Szefler, 2003, Montelukast for respiratory syncytial virus bronchiolitis. Significant effect or provocative findings?, Am J Respir Crit Care Med, 167, 290, 10.1164/rccm.2211006